Back to results
US 2023/0272091 A1Published application
Il10ra binding molecules and methods of use
AssigneeSynthekine, Inc.
InventorsRobert Kastelein, Deepti Rokkam, Patrick J. Lupardus, Sandro Vivona
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to biologically active molecules comprising a single domain antibody (sdAb) that specifically binds to the extracellular domain of human IL10Ra, compositions comprising such antibodies, and methods of use thereof.
Claims17
A IL10Ra binding molecule that specifically binds to the extracellular domain of IL10Ra.
Dependencies are inferred from the claim text.